Page last updated: 2024-11-02

4-iodoclonidine and Adenoma, beta-Cell

4-iodoclonidine has been researched along with Adenoma, beta-Cell in 1 studies

4-iodoclonidine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"The effect on insulin release of efaroxan, an alpha 2-adrenoceptor antagonist and a highly potent drug at imidazoline I1 receptors, and the effects of seven other imidazoline compounds selective for the imidazoline I1 or I2 receptors, were studied in the rat insulinoma cell line RIN-5AH."3.69Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. ( Haque, M; Kulkarni, RN; MacDermot, J; Olmos, G, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olmos, G1
Kulkarni, RN1
Haque, M1
MacDermot, J1

Other Studies

1 other study available for 4-iodoclonidine and Adenoma, beta-Cell

ArticleYear
Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    European journal of pharmacology, 1994, Sep-01, Volume: 262, Issue:1-2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Affinity Labels;

1994